Screener
AN2 Therapeutics, Inc. ANTX Q3 2025 earnings
Reported November 12, 2025 · Before market open
EPS-$0.31Miss by $0.08
EPS estimate-$0.23
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$0.20
Versus estimates
Diluted EPS
FAQ
- When did AN2 Therapeutics, Inc. report Q3 2025 earnings?
- AN2 Therapeutics, Inc. (ANTX) reported Q3 2025 earnings on November 12, 2025 before market open.
- What were AN2 Therapeutics, Inc.'s Q3 2025 revenue and EPS?
- AN2 Therapeutics, Inc. reported eps of $-0.31 for Q3 2025.
- Did AN2 Therapeutics, Inc. beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.23 by $0.08.
- How did AN2 Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 27.9% from $-0.43.
- Where can I find AN2 Therapeutics, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-277662) and the 10-Q periodic report (0001193125-25-277673) directly on SEC EDGAR. The filing index links above go to sec.gov.
